Cargando…
Lactobacillus for the treatment and prevention of atopic dermatitis: Clinical and experimental evidence
Atopic dermatitis (AD) is a chronic inflammatory skin disease, accompanied by itching and swelling. The main pathological mechanism of AD is related to the imbalance between Type 2 helper cells (Th2 cells) and Type 1 helper cells (Th1 cells). Currently, no safe and effective means to treat and preve...
Autores principales: | Xie, Anni, Chen, Ailing, Chen, Yuqing, Luo, Zichen, Jiang, Shanyu, Chen, Daozhen, Yu, Renqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978199/ https://www.ncbi.nlm.nih.gov/pubmed/36875529 http://dx.doi.org/10.3389/fcimb.2023.1137275 |
Ejemplares similares
-
Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms
por: Peng, Yijing, et al.
Publicado: (2023) -
Maternal supplementation with Limosilactobacillus reuteri FN041 for preventing infants with atopic dermatitis: study protocol for a randomized controlled trial
por: Yu, Renqiang, et al.
Publicado: (2023) -
The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment
por: Khadka, Veda D., et al.
Publicado: (2021) -
Distinct Skin Microbiota Imbalance and Responses to Clinical Treatment in Children With Atopic Dermatitis
por: Liu, Ying, et al.
Publicado: (2020) -
Dysbiotic Lesional Microbiome With Filaggrin Missense Variants Associate With Atopic Dermatitis in India
por: Nath, Shankha, et al.
Publicado: (2020)